These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11841862)

  • 1. Functional cell-based uHTS in chemical genomic drug discovery.
    Croston GE
    Trends Biotechnol; 2002 Mar; 20(3):110-5. PubMed ID: 11841862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide ligands in antibacterial drug discovery: use as inhibitors in target validation and target-based screening.
    Lapan KA; Chapple JP; Galcheva-Gargova Z; Yang M; Tao J
    Expert Opin Ther Targets; 2002 Aug; 6(4):507-16. PubMed ID: 12223065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical genomics and emerging DNA technologies in the identification of drug mechanisms and drug targets.
    Olsen LC; Færgeman NJ
    Curr Top Med Chem; 2012; 12(12):1331-45. PubMed ID: 22690680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic approaches to drug discovery.
    Ricke DO; Wang S; Cai R; Cohen D
    Curr Opin Chem Biol; 2006 Aug; 10(4):303-8. PubMed ID: 16822705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug discovery based on genomic information].
    Nohmi T
    Rinsho Byori; 2002 Jul; 50(7):694-7. PubMed ID: 12187707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical microarray: a new tool for drug screening and discovery.
    Ma H; Horiuchi KY
    Drug Discov Today; 2006 Jul; 11(13-14):661-8. PubMed ID: 16793536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases.
    Cho CH; Nuttall ME
    Expert Opin Ther Targets; 2002 Dec; 6(6):679-89. PubMed ID: 12472380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application and utilization of chemoinformatics tools in lead generation and optimization.
    Fotouhi N; Gillespie P; Goodnow RA; So SS; Han Y; Babiss LE
    Comb Chem High Throughput Screen; 2006 Feb; 9(2):95-102. PubMed ID: 16475967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In silico drug discovery based on the integration of bioinformatics and chemoinformatics].
    Okuno Y
    Yakugaku Zasshi; 2008 Nov; 128(11):1645-51. PubMed ID: 18981700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target validation and drug discovery using genomic and protein-protein interaction technologies.
    Pillutla RC; Fisher PB; Blume AJ; Goldstein NI
    Expert Opin Ther Targets; 2002 Aug; 6(4):517-31. PubMed ID: 12223066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of chemical biology in target identification and drug discovery.
    Zhu Y; Xiao T; Lei S; Zhou F; Wang MW
    Arch Pharm Res; 2015 Sep; 38(9):1642-50. PubMed ID: 26242900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tackling the chemogenomic space by novel screening technologies.
    Mayr LM
    Ernst Schering Res Found Workshop; 2006; (58):111-73. PubMed ID: 16709002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LS-align: an atom-level, flexible ligand structural alignment algorithm for high-throughput virtual screening.
    Hu J; Liu Z; Yu DJ; Zhang Y
    Bioinformatics; 2018 Jul; 34(13):2209-2218. PubMed ID: 29462237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Going to the well no more: lawn format assays for ultra-high-throughput screening.
    Marron BE; Jayawickreme CK
    Curr Opin Chem Biol; 2003 Jun; 7(3):395-401. PubMed ID: 12826128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streamlining lead discovery by aligning in silico and high-throughput screening.
    Davies JW; Glick M; Jenkins JL
    Curr Opin Chem Biol; 2006 Aug; 10(4):343-51. PubMed ID: 16822701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework.
    Yamanishi Y; Kotera M; Kanehisa M; Goto S
    Bioinformatics; 2010 Jun; 26(12):i246-54. PubMed ID: 20529913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragment informatics and computational fragment-based drug design: an overview and update.
    Sheng C; Zhang W
    Med Res Rev; 2013 May; 33(3):554-98. PubMed ID: 22430881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical genomics: a systematic approach in biological research and drug discovery.
    Zheng XF; Chan TF
    Curr Issues Mol Biol; 2002 Apr; 4(2):33-43. PubMed ID: 11931568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discovery and computational evolutionary analysis.
    Holbrook JD; Sanseau P
    Drug Discov Today; 2007 Oct; 12(19-20):826-32. PubMed ID: 17933683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.